Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.
(49/107)
(+info)
Pathogenesis of Lassa fever in cynomolgus macaques.
(50/107)
(+info)
Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report.
(51/107)
(+info)
Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.
(52/107)
(+info)
Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.
(53/107)
(+info)
Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
(54/107)
(+info)
Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.
(55/107)
(+info)
Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.
(56/107)
(+info)